Medtech Insight taps AMDR’s Dan Vukelich as an industry expert for insight into how European member states are likely to respond to the EU’s new Medical Device Regulation (MDR) which “introduces new and much tighter rules for reprocessing single-use medical devices.” In the just published article, “Could New EU Regulatory Hurdles Put Up Barriers for Would-Be Reprocessors?”, editor Amanda Maxwell explores why Vukelich suggests that the “notified body situation, among other things, will prevent in-house reprocessing from really taking off”, and paving the way for commercial reprocessors to take on a more prominent role as remanufacturers of single-use medical devices. Read More (subscription required).